BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22452524)

  • 1. Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study.
    Braga MF; Casanova A; Teoh H; Gerstein HC; Fitchett DH; Honos G; McFarlane PA; Ur E; Yale JF; Langer A; Goodman SG; Leiter LA;
    Int J Clin Pract; 2012 May; 66(5):457-64. PubMed ID: 22452524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
    Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
    Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
    Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
    Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.
    Blonde L; Woo V; Mathieu C; Yee J; Vijapurkar U; Canovatchel W; Meininger G
    Curr Med Res Opin; 2015 Nov; 31(11):1993-2000. PubMed ID: 26373629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
    De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Di Bartolo P; Pontremoli R;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1526-33. PubMed ID: 25883195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
    Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
    Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE.
    Gitt AK; Schmieder RE; Duetting E; Bramlage P; Schneider S; Tschöpe D;
    Cardiovasc Diabetol; 2012 Dec; 11():148. PubMed ID: 23216660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.
    Abraira C; Duckworth WC; Moritz T;
    Diabetes Obes Metab; 2009 Feb; 11(2):150-6. PubMed ID: 18671796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Br J Gen Pract; 2009 Jan; 59(558):43-8. PubMed ID: 19105915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
    Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting.
    Brixner DI; McAdam-Marx C; Ye X; Boye KS; Nielsen LL; Wintle M; Misurski D; Fabunmi R
    Diabetes Obes Metab; 2009 Dec; 11(12):1122-30. PubMed ID: 19930004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
    Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
    Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
    Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
    Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.